In patients with early-stage HER2-positive breast cancer in the DESTINY-Breast 05 and the DESTINY-Breast 11 trials, ...

The confirmed presence of substandard or falsified anticancer medicines in sub-Saharan Africa will complicate cancer care.

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For ...

Recent studies presented at the European Society for Medical Oncology meeting showcase promising results of antibody-drug conjugates (ADCs) in breast cancer treatment. Trials reveal significantly ...

Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from ...

Research reveals that the combination of palbociclib and telaglenastat, two drugs with complementary actions, could help ...

Adding abemaciclib to standard endocrine therapy reduces the risk of death and recurrence in patients with breast cancer.

Compugen’s Unigen AI/ML platform drives the discovery of potentially novel checkpoints. Find out what nudges me to rate CGEN ...

Market Size was valued at around US $11.9 billion in 2024, the market is projected to surge past US $30.4 billion by 2033, ...